Our epidemiology forecasts at the total, diagnosed and drug-treated levels.
The foundation for sizing market potential, profiling patient segments and informing confident forecast-based business decisions.
The broadest actual – not extrapolated – geographic coverage and most granular population segments for oncology, rare and niche diseases and beyond.
Contact us to connect with a specialist on how we can help you understand the disease landscape and size global markets